# Pharmacokinetic Drug Interaction Study Between Gemigliptin and Irbesartan After Oral Administration in Healthy Male Subjects

> **NCT01825850** · PHASE1 · COMPLETED · sponsor: **LG Life Sciences** · enrollment: 30 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Gemigliptin
- **DRUG:** Irbesartan

## Key facts

- **NCT ID:** NCT01825850
- **Lead sponsor:** LG Life Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2013-09
- **Final completion:** 2014-03
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2014-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01825850

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01825850, "Pharmacokinetic Drug Interaction Study Between Gemigliptin and Irbesartan After Oral Administration in Healthy Male Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01825850. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*